1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Allergy Immunotherapies Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Treatment Type
5.5 Market Breakup by Allergy Type
5.6 Market Breakup by Distribution Channel
5.7 Market Breakup by Region
5.8 Market Forecast
6 Market Breakup by Treatment Type
6.1 Subcutaneous Immunotherapy (SCIT)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Sublingual Immunotherapy (SLIT)
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Allergy Type
7.1 Allergic Rhinitis
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Asthma
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Food Allergy
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Venom Allergy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacy
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 Europe
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 North America
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Asia Pacific
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Latin America
9.5.1 Market Trends
9.5.2 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
13.1 Price Indicators
13.2 Price Structure
13.3 Margin Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 ALK-Abello A/S
14.3.2 Allergy Therapeutics
14.3.3 Stallergenes Greer
14.3.4 HAL Allergy Holding B.V.
14.3.5 DBV Technologies
14.3.6 Merck KGaA
14.3.7 Aimmune Therapeutics
14.3.8 Circassia Pharmaceuticals
14.3.9 Anergis SA
14.3.10 Biomay AG
世界のアレルギー免疫療法市場予測2023年-2028年 |
【英語タイトル】Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 | |
・商品コード:IMARC23FB0121 ・発行会社(調査会社):IMARC ・発行日:2023年2月1日 ・ページ数:108 ・レポート言語:英語 ・レポート形式:PDF ・納品方法:Eメール ・調査対象地域:グローバル ・産業分野:医療機器 |
Single User | USD2,999 ⇒換算¥455,848 | 見積依頼/購入/質問フォーム |
Five User | USD3,999 ⇒換算¥607,848 | 見積依頼/購入/質問フォーム |
Enterprisewide | USD4,999 ⇒換算¥759,848 | 見積依頼/購入/質問フォーム |
※販売価格オプションの説明 ※お支払金額:換算金額(日本円)+消費税 ※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡) ※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能) |
IMARC社は、2022年に28億ドルであった世界のアレルギー免疫療法市場規模が2028年に50億ドルに達し、2023年から2028年の間に年平均9.8%成長すると予測しています。本調査レポートでは、アレルギー免疫療法の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、治療種類別(皮下免疫療法(SCIT)、舌下免疫療法(SLIT))分析、アレルギー種類別(アレルギー性鼻炎、喘息、食物アレルギー、毒物アレルギー、その他)分析、流通チャネル別(病院薬局、小売薬局、オンライン薬局)分析、地域別(ヨーロッパ、北米、アジア太平洋、中東・アフリカ、中南米)分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競合状況などの項目を掲載しています。また、本調査レポートに掲載されている企業情報には、ALK-Abello A/S、Allergy Therapeutics、Stallergenes Greer、HAL Allergy Holding B.V.、DBV Technologies、Merck KGaA、Aimmune Therapeutics、Circassia Pharmaceuticals、Anergis SA、Biomay AGなどが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界のアレルギー免疫療法市場規模:治療種類別 - 皮下免疫療法(SCIT)の市場規模 - 舌下免疫療法(SLIT)の市場規模 ・世界のアレルギー免疫療法市場規模:アレルギー種類別 - アレルギー性鼻炎における市場規模 - 喘息における市場規模 - 食物アレルギーにおける市場規模 - 毒物アレルギーにおける市場規模 - その他アレルギーにおける市場規模 ・世界のアレルギー免疫療法市場規模:流通チャネル別 - 病院薬局チャネルの市場規模 - 小売薬局チャネルの市場規模 - オンライン薬局チャネルの市場規模 ・世界のアレルギー免疫療法市場規模:地域別 - ヨーロッパのアレルギー免疫療法市場規模 - 北米のアレルギー免疫療法市場規模 - アジア太平洋のアレルギー免疫療法市場規模 - 中東・アフリカのアレルギー免疫療法市場規模 - 中南米のアレルギー免疫療法市場規模 ・SWOT分析 ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競合状況 |
The global allergy immunotherapies market size reached US$ 2.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.0 Billion by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2023-2028.
Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system’s response by gradually increasing the doses of the allergen. Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient’s life.
In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world. Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global allergy immunotherapies market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on treatment type, allergy type and distribution channel.
Breakup by Treatment Type:
Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)
Breakup by Allergy Type:
Allergic Rhinitis
Asthma
Food Allergy
Venom Allergy
Others
Breakup by Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Breakup by Region:
Europe
North America
Asia Pacific
Middle East and Africa
Latin America
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Holding B.V., DBV Technologies, Merck KGaA, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, and Biomay AG, etc.
Key Questions Answered in This Report
1. What was the size of the global allergy immunotherapies market in 2022?
2. What is the expected growth rate of the global allergy immunotherapies market during 2023-2028?
3. What are the key factors driving the global allergy immunotherapies market?
4. What has been the impact of COVID-19 on the global allergy immunotherapies market?
5. What is the breakup of the global allergy immunotherapies market based on the treatment type?
6. What is the breakup of the global allergy immunotherapies market based on the allergy type?
7. What is the breakup of the global allergy immunotherapies market based on the distribution channel?
8. What are the key regions in the global allergy immunotherapies market?
9. Who are the key players/companies in the global allergy immunotherapies market?
❖ レポートの目次 ❖
★調査レポート[世界のアレルギー免疫療法市場予測2023年-2028年] (コード:IMARC23FB0121)販売に関する免責事項を必ずご確認ください。 |
★調査レポート[世界のアレルギー免疫療法市場予測2023年-2028年]についてメールでお問い合わせ |